Initial studies of dementia due to lobar atrophy (Pick's disease and Dementia of the Frontal Lobe Type, DFT) indicate neurochemical profiles distinct from that of Alzheimer's disease (AD) [1, 2] . We have examined the cortical serotonergic profile of previously frozen human brains from control patients (n=27, 178: 1 O? , age 68 f 10 yrs, postmortem delay (PMD) 30 f 20 hrs, mean f s.d.) and patients suffering from histologically confirmed Pick's disease (n=10, 28:8?, age 66 f 6 yrs, PMD 35 f 31 hrs) and DFT (n=6, 38:3?, age 65 f 7 yrs, PMD 41 f 27 hrs).
Receptor ligand binding experiments were performed on crude homogenates of frontal (Brodmann Area, BA 9), temporal (BA 21) and parietal (BA 7) cortical areas. Choline acetyl transferase (Chat) activity was determined by a modified method of Fonnum [3] . InM 3H pirenzipine, displaced with 0.1 pM pirenzipine was used to investigate Muscarinic, M, receptors. L and N type Ca" channels were quantified using I n M 3H PN 200-110 (displaced with 10pM nicarpidine) and 50pM ' 2 5 1 -~-~~n~t o~i n (displaced with 1 pM o-conotoxin)
respectively. GABA, binding was determined with 2nM %-TBPS (Butyl bicyclophosphonothionate), displaced with 4.75pM TBPS. The glutamate receptors were also investigated: NMDA (5nM 3H dizocilpine displaced with IOpM dizocilpine), AMPA (2nM 3H CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) displaced with 0.7mM glutamate) and kainate (2.5nM 3H kainate displaced with 100pM kainate). Somatostatin-like immunoreactivity (SLIR) was determined using a comercially available RIA kit (Incstar). Table 1 shows the neurochemical profiles of the control subjects, and Figure 1 indicates the neurochemical parameters in the disease states as a percentage of these.
Classically in AD, ChAT activity is significantly reduced in Alzheimer's disease, in both Pick's disease and DFT the activity of this enzyme is unaffected. In common with AD the muscarinic M, receptor is unaffected, indicating that the cholinergic system is probably normal in the lobar atrophies. Studies of the neurotransmitter receptors associated with the cortical pyramidal neurones (glutamate receptors) indicate a loss of these cells from frontal and temporal lobes in both conditions, with a possible sparing in the subpopulation expressing the kainate receptor. In DFT alone, an increase in the content of SLlR in the frontal lobe and the increase in GAB& binding suggests preservation of at least a sub-population of interneurones in this disorder.
TABLE1 Neurochemical Darameters in the cerebral cortex of control
Values are mean f SEM n=24-26 Units are fmoles/mg protein except ChAT (prnoleshg proteinhn) and SLlR (pmoleshng protein)
